Adaptive immunotherapeutic paradigms in diffuse midline glioma: integrating epigenetic reprogramming, neuron–glioma interactions, and tumor microenvironment modulation

Justin Liu, Joseph H. Ha, Matthew Abikenari, Matthew Adam Sjoholm, Shreyas Annagiri, Karthik Ravi, Brandon H. Bergsneider, Rohit Verma, Debebe Theodros, Ravi Medikonda, Gordon Li, Laura M. Prolo, Michelle Monje, Michael Lim · 2025

Read Adaptive immunotherapeutic paradigms in diffuse midline glioma: integrating epigenetic reprogramming, neuron–glioma interactions, and tumor microenvironment modulation by Justin Liu, Joseph H. Ha, Matthew Abikenari, Matthew Adam Sjoholm, Shreyas Annagiri, Karthik Ravi, Brandon H. Bergsneider, Rohit Verma, Debebe Theodros, Ravi Medikonda, Gordon Li, Laura M. Prolo, Michelle Monje, Michael Lim (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12748091.txt.

Description

Justin Liu and thirteen colleagues reviewed immunotherapy strategies for diffuse midline gliomas, among the deadliest childhood brain tumors. These tumors carry a signature histone mutation and resist nearly everything tried. The review surveys peptide vaccines against that mutation, engineered CAR T cells, checkpoint modulation, and radioimmunotherapy across preclinical and early clinical studies. Two newer angles get extended treatment: reprogramming the tumor's epigenetic state, and the electrical conversation between neurons and glioma cells.

That neuron-glioma crosstalk also suppresses immunity in the tumor's neighborhood. Adaptive strategies combine these levers, adjusting as the tumor responds, rather than firing one therapy and hoping. Survival in this disease has barely moved in decades. The twenty twenty-five review maps why single-agent immunotherapy keeps failing here and what multi-pronged trials should try instead, knowledge families and clinicians need when weighing experimental options.

Catalog record

CREATORJustin Liu, Joseph H. Ha, Matthew Abikenari, Matthew Adam Sjoholm, Shreyas Annagiri, Karthik Ravi, Brandon H. Bergsneider, Rohit Verma, Debebe Theodros, Ravi Medikonda, Gordon Li, Laura M. Prolo, Michelle Monje, Michael Lim
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE71 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12748091

Browse the full library · About the Tower of Babel